U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity

Knife River

23/12/2024 07:07

Dec 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed
companies including Hershey, Paychex and Revvity, on Monday.
     
      HIGHLIGHTS
                 * Hershey Co  HSY.N : Jefferies cuts target price to $150 from $155
 
                 * Paychex Inc  PAYX.O : Baird raises target price to $143 from $139
 
                 * Revvity Inc  RVTY.N : Jefferies cuts target price to $120 from $125
 
                 * Vertex Pharmaceuticals Inc  VRTX.O : Scotiabank raises target price to $430 from $426
 
                 * Winnebago Industries Inc  WGO.N : Jefferies cuts target price to $55 from $58
 
     
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical
order.    

                 * Aadi Bioscience Inc  AADI.O : Jefferies raises target price to $3 from $2
 
                 * B&G Foods Inc  BGS.N : Jefferies cuts target price to $8 from $9
 
                 * Calavo Growers Inc  CVGW.O : Jefferies cuts target price to $29 from $30
 
                 * Flowers Foods Inc  FLO.N : Jefferies cuts target price to $23 from $24
 
                 * Halozyme Therapeutics Inc  HALO.O : JP Morgan raises target price to $55 from $54
 
                 * Hershey Co  HSY.N : Jefferies cuts target price to $150 from $155
 
                 * Innovative Industrial Properties  IIPR.N : Piper Sandler cuts PT to $70 from $118
 
                 * Innovative Industrial Properties  IIPR.N : Piper Sandler cuts to underweight from neutral
 
                 * Ionis Pharmaceuticals Inc  IONS.O : Oppenheimer raises target price to $78 from $75
 
                 * J M Smucker Co  SJM.N : Jefferies cuts target price to $123 from $130
 
                 * JLL  JLL.N : Jefferies raises target price to $321 from $318
 
                 * Knife River Corp  KNF.N : D.A. Davidson raises target price to $125 from $120
 
                 * Lamb Weston Holdings Inc  LW.N : TD Cowen cuts target price to $62 from $79
 
                 * Legend Biotech Corp  LEGN.O : JP Morgan cuts target price to $77 from $80
 
                 * Lennar Corp  LEN.N : JP Morgan cuts target price to $152 from $173
 
                 * MGP Ingredients Inc  MGPI.O : TD Cowen cuts target price to $45 from $50
 
                 * Neurocrine Biosciences Inc  NBIX.O : Jefferies raises target price to $168 from $158
 
                 * Paychex Inc  PAYX.O : Baird raises target price to $143 from $139
 
                 * Replimune Group Inc  REPL.O : Jefferies raises target price to $31 from $19
 
                 * Revvity Inc  RVTY.N : Jefferies cuts target price to $120 from $125
 
                 * Stryker Corp  SYK.N : TD Cowen raises target price to $435 from $400
 
                 * Uniti Group Inc  UNIT.O : RBC raises target price to $6 from $5.50
 
                 * Vertex Pharmaceuticals Inc  VRTX.O : JP Morgan cuts target price to $500 from $503
 
                 * Vertex Pharmaceuticals Inc  VRTX.O : Scotiabank raises target price to $430 from $426
 
                 * Vital Farms Inc  VITL.O : Jefferies raises target price to $46 from $41
 
                 * Winnebago Industries Inc  WGO.N : Jefferies cuts target price to $55 from $58
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))